Inserm_EN

Dear followers, this twitter account will now be inactive. Thank you for joining us on @Inserm !

[Inserm_EN @Inserm_EN]

Dear followers, this twitter account will now be inactive. Thank you for joining us on @Inserm !

[Inserm_EN @Inserm_EN]

Genomic Variability 2018 @Inserm Cross-Cutting Program - Submission deadline for letters of intent: April 2, 2018
https://t.co/E2B5ag7iJy

[Inserm_EN @Inserm_EN]

While disadvantaged people use emergency departments more frequently than the most advantaged, the reasons for their visit are just as often legitimate. A finding of an @Inserm team interested in the reasons for this increased use by certain patients https://t.co/QmSaOeK5L7

[Inserm_EN @Inserm_EN]

#Diabetes : a defect in communication between two intracellular organelles - mitochondria and endoplasmic reticulum – seems to be involved in the onset of insulin resistance https://t.co/RxspBbHlKB

[Inserm_EN @Inserm_EN]

Malformation of the aortic valve: a mechanism revealed https://t.co/QtXz5qOT5s

[Inserm_EN @Inserm_EN]

[Research for and with patients] Rare Disease Day 2018 is specifically aimed at increasing patient participation in research. A day which, more than ever, is central to the work carried out at Inserm. https://t.co/Hw9GAMsgNU
#ShowYourRare #RareDiseaseDay

[Inserm_EN @Inserm_EN]

Limiting muscle aging: a nematode opens up a new approach ! At first sight, the nematode C. elegans has very little in common with humans… nevertheless, a mechanism related to muscular #aging has just been identified thanks to this worm https://t.co/sA639Xc52X

[Inserm_EN @Inserm_EN]

[Meet our Researchers] Co-discoverer of the AIDS virus and pioneer in regulatory T cell research, David Klatzmann : a translational immunologist https://t.co/l4zn2ot9AC

[Inserm_EN @Inserm_EN]

XX vs XY: If women have one more X than men, an inactivation mechanism allows equal expression of genes of both sexes. But some genes might escape it: a clue to explain the female susceptibility to autoimmune diseases...
https://t.co/SAlspsgiI3

[Inserm_EN @Inserm_EN]

Type 1 diabetes: the role of the thymus is not what we thought!
https://t.co/ogQh6k079r

[Inserm_EN @Inserm_EN]

#Migraine: Regions of the #Brain We Thought Felt No #Pain
https://t.co/EcC53HKeGa

[Inserm_EN @Inserm_EN]

International #EpilepsyDay - a feature from our magazine Science&Santé that covers what we know and what we want to know to better treat epilepsy
https://t.co/4NJwhJcRiW

[Inserm_EN @Inserm_EN]

Dendrogenin A, a cholesterol derivative, led to autophagy in human cancer cells. A discovery that paves the way for new possibilities in the treatment of #cancers
https://t.co/AbuJqULx7H
#Toulouse

[Inserm_EN @Inserm_EN]

The study of endocrine disruptors is of great importance to health & environment. However, this research raises several challenges. Explore current scientific knowledge and research about #endocrinedisruptors https://t.co/k8Vgb1aZFF

[Inserm_EN @Inserm_EN]

The primary cilium, a potential therapeutic target in the fight against the #fibrosis encountered in #obesity and certain muscle diseases such as #DuchenneMuscularDystrophy https://t.co/PjRxovqkAF

[Inserm_EN @Inserm_EN]

Already known for being an intracellular mediator, the SRC protein actually plays a bigger role: it also controls the production of the exosomes that cancer cells excrete into their environment. A discovery which can lead to new therapeutic avenues! https://t.co/G5buVQmcQU

[Inserm_EN @Inserm_EN]

With a conventional microscope, measuring anything less than 200 nanometers is impossible. But with simulated emission depletion (STED) #microscopy and Sophie Allart's work, this limit has been lowered to 23 nanometers! https://t.co/bhznNLZr9X
#innovation

[Inserm_EN @Inserm_EN]

Could the Biological Clock Be a Key Ally in the Fight Against Inflammatory Disease? https://t.co/PZWTKsqm7e

[Inserm_EN @Inserm_EN]

Immunizing against #pain is a novel idea to say the least, but @Inserm researchers show that it is far from being a utopia. They have indeed recently proven, in mice, that a vaccination can alleviate visceral pain. https://t.co/8uy3oZ1u0b

[Inserm_EN @Inserm_EN]

Gene therapy and genetic variability, global network and national plans: Yves Lévy presents the Inserm roadmap for 2018 https://t.co/P7MelJBQ5z